Evidence map›Paper›PMID 42232002›Full record

ArticleCureus2026

Long-Term Outcomes and Safety of Surgical Treatment Following Intracranial Electroencephalography Monitoring in Pediatric Epilepsy: A Single-Center Study.

Takafumi Shimogawa, Takato Morioka, Kimiaki Hashiguchi, Nobuya Murakami, Nobutaka Mukae, Hiroshi Shigeto, Yasunari Sakai, Ayumi Sakata, Akira Nakamizo, Koji Yoshimoto

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takafumi ShimogawaDepartment of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.
Takato MoriokaDepartment of Neurosurgery, Hachisuga Hospital, Munakata, JPN.
Kimiaki HashiguchiDepartment of Neurosurgery, Hashiguchi Neuro Clinic, Fukuoka, JPN.
Nobuya MurakamiDepartment of Neurosurgery, Fukuoka Children's Hospital, Fukuoka, JPN.
Nobutaka MukaeDepartment of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.
Hiroshi ShigetoDepartment of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.
Yasunari SakaiDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.
Ayumi SakataDepartment of Health Sciences, Faculty of Medical Sciences, Kyushu University, Fukuoka, JPN.
Akira NakamizoDepartment of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.
Koji YoshimotoDepartment of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIntracranial electroencephalography (iEEG) monitoring presents additional challenges in pediatric patients compared to adults due to factors such as smaller body size, increased surgical invasiveness, difficulty maintaining rest, higher sensitivity to pain, and a greater risk of electrode self-removal. However, long-term outcomes and complications following resective surgery after iEEG evaluation in children remain underreported. This study aimed to evaluate the long-term outcomes and safety of surgical treatment following iEEG monitoring in pediatric patients.

methodsWe retrospectively analyzed 24 pediatric patients (aged ≤15 years) who underwent surgical treatment after iEEG implantation between 1994 and 2024, with a minimum follow-up period of 5 years. Clinical characteristics, neuroimaging findings, details of iEEG monitoring, surgical procedures, epilepsy etiology, and seizure outcomes were reviewed.

resultsThe mean age at epilepsy onset was 4.5 years (range, 0.0-12.0), and the mean age at surgery was 10.4 years (range, 1.8-14.0). The average interval from seizure onset to surgery was 6.0 years (range, 0.9-14.8). The iEEG modalities included subdural grid electrodes alone (15 patients), a combination of subdural and depth electrodes (eight patients), and depth electrodes alone (one patient). The mean duration of iEEG monitoring was 9.1 days (range, 2-14). Surgical procedures included focal cortical resection and/or lesionectomy in 18 patients (75.0%), anterior temporal lobectomy in five (20.8%), and multiple subpial transections (MST) alone in one (4.2%). MST, in addition to resection, was performed in six patients (25.0%). Thirteen patients (54.2%) achieved Engel class I or II outcomes. No perioperative complications related to iEEG implantation occurred, and no patients experienced permanent neurological deterioration. Blood transfusion was not required in any case. MEG-MRI (magnetoencephalography-magnetic resonance imaging) concordance was significantly associated with favorable seizure outcomes.

conclusionThis study demonstrated a good seizure outcome rate of 54.2% in pediatric patients who underwent surgical treatment following iEEG monitoring. No major perioperative complications related to iEEG implantation were observed, and no patients experienced permanent neurological deterioration in this cohort. These findings suggest that with careful electrode selection, precise placement and fixation, and vigilant perioperative management, iEEG can be safely performed even in very young children. Furthermore, the presence of MEG clusters concordant with MRI lesions tended to be associated with better seizure outcomes after resection, suggesting a possible role of multimodal imaging data in individualized treatment planning.

Indexed as

intracranial electroencephalographylong-term seizure outcomespediatric epilepsypediatric epilepsy surgerysafety

Identifiers

PMID42232002
PMCPMC13222874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.